Migraine : pharmacology and genetics
Author(s)
Bibliographic Information
Migraine : pharmacology and genetics
Altman, 1996
Available at 3 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Description and Table of Contents
Description
The drug treatment of migraine is an area of intense research and development by the pharmaceutical industry. This study developed out of a meeting, and deals with the current areas of research activity and the clinical implications.
Table of Contents
5HT receptor subtypes
Central and peripheral 5HT receptor effects
PET scan studies
Recurrence after 5HT1D agonist treatment - clinical
Recurrence after 5HT1D agonist treatment - pharmacological
Evoked potentials in migraine: indicators of abnormal CNS neurotransmission
GABA receptors
Somatostatin receptors
Neurotrophins
Neuropeptides
Familial hemiplegic syndromes
Comorbidity
Chromesome 19 in migraine with and without aura
Models for the genetics of migraine.
by "Nielsen BookData"